United States Gene Therapy Market Report 2018

February 2018 | 103 pages | ID: UC7ACB18F2EEN
QYResearch

Abstracts

In this report, the United States Gene Therapy market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Gene Therapy in these regions, from 2013 to 2025 (forecast).

United States Gene Therapy market competition by top manufacturers/players, with Gene Therapy sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Sangamo
• Spark Therapeutics
• Dimension Therapeutics
• Avalanche Bio
• Celladon
• Vical
• Advantagene

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Ex vivo
• In vivo

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Cancer Diseases
• Monogenic Diseases
• Infectious Diseases
• Cardiovascular Diseases
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Gene Therapy Market Report 2018

1 GENE THERAPY OVERVIEW

1.1 Product Overview and Scope of Gene Therapy
1.2 Classification of Gene Therapy by Product Category
  1.2.1 United States Gene Therapy Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Gene Therapy Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Ex vivo
  1.2.4 In vivo
1.3 United States Gene Therapy Market by Application/End Users
  1.3.1 United States Gene Therapy Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Cancer Diseases
  1.3.3 Monogenic Diseases
  1.3.4 Infectious Diseases
  1.3.5 Cardiovascular Diseases
  1.3.6 Others
1.4 United States Gene Therapy Market by Region
  1.4.1 United States Gene Therapy Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Gene Therapy Status and Prospect (2013-2025)
  1.4.3 Southwest Gene Therapy Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Gene Therapy Status and Prospect (2013-2025)
  1.4.5 New England Gene Therapy Status and Prospect (2013-2025)
  1.4.6 The South Gene Therapy Status and Prospect (2013-2025)
  1.4.7 The Midwest Gene Therapy Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Gene Therapy (2013-2025)
  1.5.1 United States Gene Therapy Sales and Growth Rate (2013-2025)
  1.5.2 United States Gene Therapy Revenue and Growth Rate (2013-2025)

2 UNITED STATES GENE THERAPY MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Gene Therapy Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Gene Therapy Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Gene Therapy Average Price by Players/Suppliers (2013-2018)
2.4 United States Gene Therapy Market Competitive Situation and Trends
  2.4.1 United States Gene Therapy Market Concentration Rate
  2.4.2 United States Gene Therapy Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Gene Therapy Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES GENE THERAPY SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Gene Therapy Sales and Market Share by Region (2013-2018)
3.2 United States Gene Therapy Revenue and Market Share by Region (2013-2018)
3.3 United States Gene Therapy Price by Region (2013-2018)

4 UNITED STATES GENE THERAPY SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Gene Therapy Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Gene Therapy Revenue and Market Share by Type (2013-2018)
4.3 United States Gene Therapy Price by Type (2013-2018)
4.4 United States Gene Therapy Sales Growth Rate by Type (2013-2018)

5 UNITED STATES GENE THERAPY SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Gene Therapy Sales and Market Share by Application (2013-2018)
5.2 United States Gene Therapy Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES GENE THERAPY PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Sangamo
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Gene Therapy Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Sangamo Gene Therapy Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Spark Therapeutics
  6.2.2 Gene Therapy Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Spark Therapeutics Gene Therapy Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Dimension Therapeutics
  6.3.2 Gene Therapy Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Dimension Therapeutics Gene Therapy Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Avalanche Bio
  6.4.2 Gene Therapy Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Avalanche Bio Gene Therapy Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Celladon
  6.5.2 Gene Therapy Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Celladon Gene Therapy Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Vical
  6.6.2 Gene Therapy Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Vical Gene Therapy Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Advantagene
  6.7.2 Gene Therapy Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Advantagene Gene Therapy Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview

7 GENE THERAPY MANUFACTURING COST ANALYSIS

7.1 Gene Therapy Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Gene Therapy

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Gene Therapy Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Gene Therapy Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES GENE THERAPY MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Gene Therapy Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Gene Therapy Sales Volume Forecast by Type (2018-2025)
11.3 United States Gene Therapy Sales Volume Forecast by Application (2018-2025)
11.4 United States Gene Therapy Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Gene Therapy
Figure United States Gene Therapy Market Size (K Units) by Type (2013-2025)
Figure United States Gene Therapy Sales Volume Market Share by Type (Product Category) in 2017
Figure Ex vivo Product Picture
Figure In vivo Product Picture
Figure United States Gene Therapy Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Gene Therapy by Application in 2017
Figure Cancer Diseases Examples
Table Key Downstream Customer in Cancer Diseases
Figure Monogenic Diseases Examples
Table Key Downstream Customer in Monogenic Diseases
Figure Infectious Diseases Examples
Table Key Downstream Customer in Infectious Diseases
Figure Cardiovascular Diseases Examples
Table Key Downstream Customer in Cardiovascular Diseases
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Gene Therapy Market Size (Million USD) by Region (2013-2025)
Figure The West Gene Therapy Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Gene Therapy Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Gene Therapy Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Gene Therapy Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Gene Therapy Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Gene Therapy Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Gene Therapy Sales (K Units) and Growth Rate (2013-2025)
Figure United States Gene Therapy Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Gene Therapy Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Gene Therapy Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Gene Therapy Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Gene Therapy Sales Share by Players/Suppliers
Figure 2017 United States Gene Therapy Sales Share by Players/Suppliers
Figure United States Gene Therapy Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Gene Therapy Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Gene Therapy Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Gene Therapy Revenue Share by Players/Suppliers
Figure 2017 United States Gene Therapy Revenue Share by Players/Suppliers
Table United States Market Gene Therapy Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Gene Therapy Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Gene Therapy Market Share of Top 3 Players/Suppliers
Figure United States Gene Therapy Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Gene Therapy Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Gene Therapy Product Category
Table United States Gene Therapy Sales (K Units) by Region (2013-2018)
Table United States Gene Therapy Sales Share by Region (2013-2018)
Figure United States Gene Therapy Sales Share by Region (2013-2018)
Figure United States Gene Therapy Sales Market Share by Region in 2017
Table United States Gene Therapy Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Gene Therapy Revenue Share by Region (2013-2018)
Figure United States Gene Therapy Revenue Market Share by Region (2013-2018)
Figure United States Gene Therapy Revenue Market Share by Region in 2017
Table United States Gene Therapy Price (USD/Unit) by Region (2013-2018)
Table United States Gene Therapy Sales (K Units) by Type (2013-2018)
Table United States Gene Therapy Sales Share by Type (2013-2018)
Figure United States Gene Therapy Sales Share by Type (2013-2018)
Figure United States Gene Therapy Sales Market Share by Type in 2017
Table United States Gene Therapy Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Gene Therapy Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Gene Therapy by Type (2013-2018)
Figure Revenue Market Share of Gene Therapy by Type in 2017
Table United States Gene Therapy Price (USD/Unit) by Types (2013-2018)
Figure United States Gene Therapy Sales Growth Rate by Type (2013-2018)
Table United States Gene Therapy Sales (K Units) by Application (2013-2018)
Table United States Gene Therapy Sales Market Share by Application (2013-2018)
Figure United States Gene Therapy Sales Market Share by Application (2013-2018)
Figure United States Gene Therapy Sales Market Share by Application in 2017
Table United States Gene Therapy Sales Growth Rate by Application (2013-2018)
Figure United States Gene Therapy Sales Growth Rate by Application (2013-2018)
Table Sangamo Basic Information List
Table Sangamo Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sangamo Gene Therapy Sales Growth Rate (2013-2018)
Figure Sangamo Gene Therapy Sales Market Share in United States (2013-2018)
Figure Sangamo Gene Therapy Revenue Market Share in United States (2013-2018)
Table Spark Therapeutics Basic Information List
Table Spark Therapeutics Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Spark Therapeutics Gene Therapy Sales Growth Rate (2013-2018)
Figure Spark Therapeutics Gene Therapy Sales Market Share in United States (2013-2018)
Figure Spark Therapeutics Gene Therapy Revenue Market Share in United States (2013-2018)
Table Dimension Therapeutics Basic Information List
Table Dimension Therapeutics Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Dimension Therapeutics Gene Therapy Sales Growth Rate (2013-2018)
Figure Dimension Therapeutics Gene Therapy Sales Market Share in United States (2013-2018)
Figure Dimension Therapeutics Gene Therapy Revenue Market Share in United States (2013-2018)
Table Avalanche Bio Basic Information List
Table Avalanche Bio Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Avalanche Bio Gene Therapy Sales Growth Rate (2013-2018)
Figure Avalanche Bio Gene Therapy Sales Market Share in United States (2013-2018)
Figure Avalanche Bio Gene Therapy Revenue Market Share in United States (2013-2018)
Table Celladon Basic Information List
Table Celladon Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Celladon Gene Therapy Sales Growth Rate (2013-2018)
Figure Celladon Gene Therapy Sales Market Share in United States (2013-2018)
Figure Celladon Gene Therapy Revenue Market Share in United States (2013-2018)
Table Vical Basic Information List
Table Vical Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Vical Gene Therapy Sales Growth Rate (2013-2018)
Figure Vical Gene Therapy Sales Market Share in United States (2013-2018)
Figure Vical Gene Therapy Revenue Market Share in United States (2013-2018)
Table Advantagene Basic Information List
Table Advantagene Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Advantagene Gene Therapy Sales Growth Rate (2013-2018)
Figure Advantagene Gene Therapy Sales Market Share in United States (2013-2018)
Figure Advantagene Gene Therapy Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gene Therapy
Figure Manufacturing Process Analysis of Gene Therapy
Figure Gene Therapy Industrial Chain Analysis
Table Raw Materials Sources of Gene Therapy Major Players/Suppliers in 2017
Table Major Buyers of Gene Therapy
Table Distributors/Traders List
Figure United States Gene Therapy Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Gene Therapy Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Gene Therapy Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Gene Therapy Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Gene Therapy Sales Volume (K Units) Forecast by Type in 2025
Table United States Gene Therapy Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Gene Therapy Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Gene Therapy Sales Volume (K Units) Forecast by Application in 2025
Table United States Gene Therapy Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Gene Therapy Sales Volume Share Forecast by Region (2018-2025)
Figure United States Gene Therapy Sales Volume Share Forecast by Region (2018-2025)
Figure United States Gene Therapy Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources